Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7585748

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,377,000,000 JPY
2,602,000,000 JPY
Interest and dividends received
52,000,000 JPY
44,000,000 JPY
Interest paid
-89,000,000 JPY
-94,000,000 JPY
Income taxes paid
-36,000,000 JPY
-606,000,000 JPY
Net cash provided by (used in) operating activities
1,305,000,000 JPY
1,945,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-623,000,000 JPY
-646,000,000 JPY
Net cash provided by (used in) investing activities
-386,000,000 JPY
-610,000,000 JPY
Proceeds from sale of investment securities
242,000,000 JPY
JPY
Other, net
-16,000,000 JPY
-69,000,000 JPY
Cash flows from financing activities
Dividends paid
-262,000,000 JPY
-262,000,000 JPY
Proceeds from long-term borrowings
2,680,000,000 JPY
2,540,000,000 JPY
Repayments of long-term borrowings
-1,980,000,000 JPY
-2,006,000,000 JPY
Net cash provided by (used in) financing activities
434,000,000 JPY
268,000,000 JPY
Other, net
-2,000,000 JPY
-2,000,000 JPY
Net increase (decrease) in cash and cash equivalents
1,352,000,000 JPY
1,603,000,000 JPY
Cash and cash equivalents
8,699,000,000 JPY
7,347,000,000 JPY
8,677,000,000 JPY
7,074,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.